BIOMAT Database Logo BIOMAT Database Logo

Synthesis of [5-isoleucine, 8-alanine]-angiotensin II by the solution method synthesis and the solid-phase method synthesis. 1967

W K Park, and R R Smeby, and F M Bumpus

UI MeSH Term Description Entries
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D012996 Solutions The homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (the solvent), from which the dissolved substances can be recovered by physical processes. (From Grant & Hackh's Chemical Dictionary, 5th ed) Solution
D014662 Vasoconstrictor Agents Drugs used to cause constriction of the blood vessels. Vasoactive Agonist,Vasoactive Agonists,Vasoconstrictor,Vasoconstrictor Agent,Vasoconstrictor Drug,Vasopressor Agent,Vasopressor Agents,Vasoconstrictor Drugs,Vasoconstrictors,Agent, Vasoconstrictor,Agent, Vasopressor,Agents, Vasoconstrictor,Agents, Vasopressor,Agonist, Vasoactive,Agonists, Vasoactive,Drug, Vasoconstrictor,Drugs, Vasoconstrictor

Related Publications

W K Park, and R R Smeby, and F M Bumpus
Solid-phase peptide synthesis of [L-alanine 3-L-isoleucine 5]-angiotensin II.
March 1967, Biochemistry,
W K Park, and R R Smeby, and F M Bumpus
Synthesis of isoleucine-5-tyrosine-8-angiotensin II and isoleucine-5-hydroxyproline-7-angiotensin II.
April 1966, Biochemistry,
W K Park, and R R Smeby, and F M Bumpus
Solid-phase synthesis of (3-proline,8-isoleucine)-,(1-sarcosine,3-proline,8-isoleucine)-, and (4-phenylalanine,8-isoleucine)angiotensin II as the antagonists of the parent hormone.
October 1973, Journal of medicinal chemistry,
W K Park, and R R Smeby, and F M Bumpus
The solid phase syntheses of 5-isoleucine-angiotensin I and 5-isoleucine (10-14C(U),-leucine)-angiotensin I.
June 1968, Life sciences,
W K Park, and R R Smeby, and F M Bumpus
Synthesis of [1-Isoleucine-, 3-proline-, and 5-alanine]-angiotensins. II.
October 1968, Biochemistry,
W K Park, and R R Smeby, and F M Bumpus
Solid-phase synthesis of (6-arginine)-, (4-histidine, 6-tyrosine)-, and (8-isoleucine)angiotensins II.
June 1972, Journal of medicinal chemistry,
W K Park, and R R Smeby, and F M Bumpus
Synthesis of peptides with the solid phase method. II. Octapeptide analogues of angiotensin II.
February 1974, Canadian journal of biochemistry,
W K Park, and R R Smeby, and F M Bumpus
Antagonism of peripheral and central effects of angiotensin II by (1-sarcosine, 8-isoleucine)angiotensin II.
April 1973, The Journal of pharmacology and experimental therapeutics,
W K Park, and R R Smeby, and F M Bumpus
Synthesis of analogs of (8-isoleucine)angiotensin II with variations in position 1.
April 1974, Journal of medicinal chemistry,
W K Park, and R R Smeby, and F M Bumpus
Synthesis and pharmacological properties of [5-isoleucine]-, [8-isoleucine]-, and [5,8-diisoleucine]bradykinin.
March 1979, Journal of medicinal chemistry,
Copied contents to your clipboard!